本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Editas Medicine, Inc.

2.58
-0.0200-0.77%
盘后2.600.0200+0.78%18:23 EST
成交量:123.84万
成交额:321.17万
市值:2.52亿
市盈率:-1.10
高:2.67
开:2.59
低:2.50
收:2.60
52周最高:4.54
52周最低:0.9101
股本:9,761.87万
流通股本:8,958.36万
量比:0.64
换手率:1.38%
股息:- -
股息率:- -
每股收益(TTM):-2.3493
每股收益(LYR):-2.8795
净资产收益率:-211.37%
总资产收益率:-28.26%
市净率:18.72
市盈率(LYR):-0.90

数据加载中...

2022/08/03

重要事件披露

8-K - Current report
2022/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/13

重要事件披露

8-K - Current report
2022/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/04

重要事件披露

8-K - Current report
2022/04/14

重要事件披露

8-K - Current report
2022/03/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/07

重要事件披露

8-K - Current report
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/10

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/28

持股变动声明

3 - Initial statement of beneficial ownership of securities
2021/10/28

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/20

持股变动声明

4 - Statement of changes in beneficial ownership of securities